Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
Lifecore Biomedical (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), has announced its participation in the upcoming Craig-Hallum Bioprocessing Conference on September 19, 2024. The event will be held virtually, featuring a fireside chat with Lifecore's leadership:
- Paul Josephs, President and CEO
- Ryan Lake, CFO
The fireside chat is scheduled for 3:30 p.m. Eastern on September 19. In addition to the chat, the executives will participate in one-on-one meetings during the conference. A webcast replay of the fireside chat will be made available on Lifecore's investor website following the event.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione completamente integrata di sviluppo e produzione su contratto (CDMO), ha annunciato la sua partecipazione alla prossima Craig-Hallum Bioprocessing Conference che si terrà il 19 settembre 2024. L'evento si svolgerà virtualmente e includerà una chiacchierata informale con i leader di Lifecore:
- Paul Josephs, Presidente e CEO
- Ryan Lake, CFO
La chiacchierata è programmata per le 15:30 Eastern del 19 settembre. Oltre alla chiacchierata, i dirigenti parteciperanno a incontri individuali durante la conferenza. Una registrazione del webcast della chiacchierata sarà disponibile sul sito web per gli investitori di Lifecore dopo l'evento.
Lifecore Biomedical (NASDAQ: LFCR), una organización de desarrollo y fabricación por contrato (CDMO) completamente integrada, ha anunciado su participación en la próxima Craig-Hallum Bioprocessing Conference que se llevará a cabo el 19 de septiembre de 2024. El evento se celebrará de forma virtual e incluirá una charla informal con el liderazgo de Lifecore:
- Paul Josephs, Presidente y CEO
- Ryan Lake, CFO
La charla está programada para las 3:30 p.m. Eastern del 19 de septiembre. Además de la charla, los ejecutivos participarán en reuniones uno a uno durante la conferencia. Una repetición del webcast de la charla estará disponible en el sitio web de inversores de Lifecore después del evento.
Lifecore Biomedical (NASDAQ: LFCR)은 완전 통합 계약 개발 및 제조 조직 (CDMO)으로서 오는 Craig-Hallum Bioprocessing Conference에 참여한다고 발표했습니다. 이 행사는 2024년 9월 19일에 가상으로 개최됩니다. 행사에서는 Lifecore의 경영진과의 fireside chat이 포함됩니다:
- Paul Josephs, 회장 겸 CEO
- Ryan Lake, CFO
이 fireside chat은 9월 19일 오후 3시 30분 (동부 표준시)에 예정되어 있습니다. 대화 외에도, 경영진은 회의 기간 동안 일대일 회의에 참여할 예정입니다. 이 fireside chat의 웹캐스트 재생은 이벤트 후 Lifecore의 투자자 웹사이트에서 제공될 것입니다.
Lifecore Biomedical (NASDAQ: LFCR), une organisation intégrée de développement et de fabrication sous contrat (CDMO), a annoncé sa participation à la prochaine Craig-Hallum Bioprocessing Conference prévue le 19 septembre 2024. L'événement se déroulera virtuellement et comportera une discussion informelle avec les dirigeants de Lifecore :
- Paul Josephs, Président et CEO
- Ryan Lake, CFO
La discussion est prévue pour 15h30, heure de l'Est le 19 septembre. En plus de cette discussion, les dirigeants participeront à des réunions individuelles durant la conférence. Une rediffusion du webcast de la discussion sera mise à disposition sur le site des investisseurs de Lifecore après l'événement.
Lifecore Biomedical (NASDAQ: LFCR), ein vollständig integriertes Auftragsentwicklungs- und Herstellungsunternehmen (CDMO), hat die Teilnahme an der bevorstehenden Craig-Hallum Bioprocessing Conference am 19. September 2024 bekannt gegeben. Die Veranstaltung findet virtuell statt und wird ein Fireside Chat mit der Führungsebene von Lifecore beinhalten:
- Paul Josephs, Präsident und CEO
- Ryan Lake, CFO
Der Fireside Chat ist für 15:30 Uhr Eastern am 19. September angesetzt. Neben dem Chat werden die Führungskräfte an Einzelgesprächen während der Konferenz teilnehmen. Eine Webcast-Wiederholung des Fireside Chats wird nach der Veranstaltung auf der Investorenseite von Lifecore verfügbar sein.
- None.
- None.
CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the Company’s president and chief executive officer, and Ryan Lake, the Company’s chief financial officer, will be the featured speakers in a fireside chat at the upcoming Craig-Hallum Bioprocessing Conference. The conference will take place virtually on September 19, 2024.
Details are as follows:
- Craig-Hallum Bioprocessing Conference
Details: Mr. Josephs and Mr. Lake will participate in a fireside chat and in 1-on-1 meetings
Conference Dates: September 19, 2024
Fireside Chat Timing: 3:30 p.m. Eastern on Thursday, September 19, 2024
Format: Virtual
Following the fireside chat, a webcast replay will be available via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Lifecore’s website at www.lifecore.com.
FAQ
When is Lifecore Biomedical (LFCR) participating in the Craig-Hallum Bioprocessing Conference?
Who will represent Lifecore Biomedical (LFCR) at the Craig-Hallum Bioprocessing Conference?
What time is Lifecore Biomedical's (LFCR) fireside chat at the Craig-Hallum conference?
Will there be a replay available of Lifecore Biomedical's (LFCR) fireside chat?
